Skip to main content
. 2020 May 7;34(8):2074–2086. doi: 10.1038/s41375-020-0826-9

Table 2.

Frequency of ACA.

Karyotypes Single ACA In combination with other ACA Total
High-risk ACA (n = 91)a
+8 19 19 38
 At diagnosis 6 10 16
 In the course of disease 13 9 22
+Ph 18 17 35
 At diagnosis 7 6 13
 In the course of disease 11 11 22
+19 0 11 11
 At diagnosis 0 4 4
 In the course of disease 0 7 7
+17/i(17q) 3 5 8
 At diagnosis 1 3 4
 In the course of disease 2 2 4
3q26.2 10 2 12
 At diagnosis 1 0 1
 In the course of disease 9 2 9
−7/7q abnormalities 5 4 9
 At diagnosis 1 0 1
 In the course of disease 4 4 8
+21 2 3 5
 At diagnosis 1 1 2
 In the course of disease 1 2 3
11q23 1 0 1
 At diagnosis 0 0 0
 In the course of disease 1 0 1
Complex karyotypes 25 25
 At diagnosis 11 11
 In the course of disease 14 14
Low-risk ACA 32 32
 At diagnosis 19 19
 In the course of disease 13 13

aMultiple listings possible.